Literature DB >> 20373033

Effects of farnesoid X receptor on the expression of the fatty acid synthetase and hepatic lipase.

Li-Li Shen1, Hong Liu, Jiahe Peng, Lin Gan, Li Lu, Qian Zhang, Liangpeng Li, Fengtian He, Yu Jiang.   

Abstract

The farnesoid X receptor (FXR) is a nuclear receptor that regulates gene expression in response to bile acids (BAs). FXR plays an important role in the homeostasis of bile acid, cholesterol, lipoprotein and triglyceride. In this report, we identified fatty acid synthase (FAS) and hepatic lipase (HL) genes as novel target genes of FXR. Human hepatoma HepG2 cells were treated with chenodeoxycholic acid, the natural FXR ligand, and the messenger RNA and protein levels of FAS and HL were determined by RT-PCR and Western blot analysis, respectively. Chenodeoxycholic acid (CDCA) down-regulated the expression of FAS and HL genes in a dose and time-dependent manner in human hepatoma HepG2 cells. In addition, treatment of mice with CDCA significantly decreased the expression of FAS and HL in mouse liver and the activity of HL. These results demonstrated that FAS and HL might be FXR-regulated genes in liver cells. In view of the role of FAS and HL in lipogenesis and plasma lipoprotein metabolism, our results further support the central role of FXR in the homeostasis of fatty acid and lipid.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20373033     DOI: 10.1007/s11033-010-0140-0

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  26 in total

Review 1.  Regulation of bile acid synthesis: pathways, nuclear receptors, and mechanisms.

Authors:  John Y L Chiang
Journal:  J Hepatol       Date:  2004-03       Impact factor: 25.083

2.  Identification of thyroid hormone response elements in the human fatty acid synthase promoter.

Authors:  S Xiong; S S Chirala; M H Hsu; S J Wakil
Journal:  Proc Natl Acad Sci U S A       Date:  1998-10-13       Impact factor: 11.205

3.  Activation of the farnesoid X receptor improves lipid metabolism in combined hyperlipidemic hamsters.

Authors:  Stefan Bilz; Varman Samuel; Katsutaro Morino; David Savage; Cheol Soo Choi; Gerald I Shulman
Journal:  Am J Physiol Endocrinol Metab       Date:  2005-11-15       Impact factor: 4.310

4.  In vivo evidence for both lipolytic and nonlipolytic function of hepatic lipase in the metabolism of HDL.

Authors:  K A Dugi; M J Amar; C C Haudenschild; R D Shamburek; A Bensadoun; R F Hoyt; J Fruchart-Najib; Z Madj; H B Brewer; S Santamarina-Fojo
Journal:  Arterioscler Thromb Vasc Biol       Date:  2000-03       Impact factor: 8.311

5.  Roles of nuclear receptors in the up-regulation of hepatic cholesterol 7alpha-hydroxylase by cholestyramine in rats.

Authors:  Shinya Shibata; Kazuhito Hayakawa; Yukari Egashira; Hiroo Sanada
Journal:  Life Sci       Date:  2006-10-14       Impact factor: 5.037

6.  Bile acids lower triglyceride levels via a pathway involving FXR, SHP, and SREBP-1c.

Authors:  Mitsuhiro Watanabe; Sander M Houten; Li Wang; Antonio Moschetta; David J Mangelsdorf; Richard A Heyman; David D Moore; Johan Auwerx
Journal:  J Clin Invest       Date:  2004-05       Impact factor: 14.808

7.  Insulin-responsive regions of the rat fatty acid synthase gene promoter.

Authors:  S S Wolf; G Hofer; K F Beck; K Roder; M Schweizer
Journal:  Biochem Biophys Res Commun       Date:  1994-09-15       Impact factor: 3.575

8.  Farnesoid X receptor represses hepatic lipase gene expression.

Authors:  Audrey Sirvent; Adrie J M Verhoeven; Hans Jansen; Vladimir Kosykh; Raphaël J Darteil; Dean W Hum; Jean-Charles Fruchart; Bart Staels
Journal:  J Lipid Res       Date:  2004-09-01       Impact factor: 5.922

Review 9.  Triglycerides and remnant particles as risk factors for coronary artery disease.

Authors:  Takamitsu Nakamura; Kiyotaka Kugiyama
Journal:  Curr Atheroscler Rep       Date:  2006-03       Impact factor: 5.113

10.  Human fatty acid synthase: properties and molecular cloning.

Authors:  A Jayakumar; M H Tai; W Y Huang; W al-Feel; M Hsu; L Abu-Elheiga; S S Chirala; S J Wakil
Journal:  Proc Natl Acad Sci U S A       Date:  1995-09-12       Impact factor: 11.205

View more
  11 in total

1.  Ursodeoxycholic Acid Suppresses Lipogenesis in Mouse Liver: Possible Role of the Decrease in β-Muricholic Acid, a Farnesoid X Receptor Antagonist.

Authors:  Kyosuke Fujita; Yusuke Iguchi; Mizuho Une; Shiro Watanabe
Journal:  Lipids       Date:  2017-03-17       Impact factor: 1.880

Review 2.  Treatment of nonalcoholic fatty liver disease in adults and children: a closer look at the arsenal.

Authors:  Valerio Nobili; Arun J Sanyal
Journal:  J Gastroenterol       Date:  2011-10-08       Impact factor: 7.527

Review 3.  Changes in Bile Acid Metabolism, Transport, and Signaling as Central Drivers for Metabolic Improvements After Bariatric Surgery.

Authors:  Matthew G Browning; Bernardo M Pessoa; Jad Khoraki; Guilherme M Campos
Journal:  Curr Obes Rep       Date:  2019-06

Review 4.  Nuclear receptors and nonalcoholic fatty liver disease.

Authors:  Matthew C Cave; Heather B Clair; Josiah E Hardesty; K Cameron Falkner; Wenke Feng; Barbara J Clark; Jennifer Sidey; Hongxue Shi; Bashar A Aqel; Craig J McClain; Russell A Prough
Journal:  Biochim Biophys Acta       Date:  2016-03-04

Review 5.  Nuclear Receptors as Therapeutic Targets in Liver Disease: Are We There Yet?

Authors:  Swetha Rudraiah; Xi Zhang; Li Wang
Journal:  Annu Rev Pharmacol Toxicol       Date:  2016       Impact factor: 13.820

6.  Mining Public Toxicogenomic Data Reveals Insights and Challenges in Delineating Liver Steatosis Adverse Outcome Pathways.

Authors:  Mohamed Diwan M AbdulHameed; Venkat R Pannala; Anders Wallqvist
Journal:  Front Genet       Date:  2019-10-18       Impact factor: 4.599

7.  The Effects of PPAR Agonists on Atherosclerosis and Nonalcoholic Fatty Liver Disease in ApoE-/-FXR-/- Mice.

Authors:  Yenna Lee; Bo-Rahm Kim; Geun-Hyung Kang; Gwan Jae Lee; Young Joo Park; Haeryoung Kim; Hak Chul Jang; Sung Hee Choi
Journal:  Endocrinol Metab (Seoul)       Date:  2021-12-28

Review 8.  Non-alcoholic steatohepatitis and hepatocellular carcinoma: implications for lycopene intervention.

Authors:  Blanche C Ip; Xiang-Dong Wang
Journal:  Nutrients       Date:  2013-12-27       Impact factor: 5.717

Review 9.  O-GlcNAcylation and the Metabolic Shift in High-Proliferating Cells: All the Evidence Suggests that Sugars Dictate the Flux of Lipid Biogenesis in Tumor Processes.

Authors:  Steffi F Baldini; Tony Lefebvre
Journal:  Front Oncol       Date:  2016-01-22       Impact factor: 6.244

10.  An EAV-HP insertion in the 5' flanking region of SLCO1B3 is associated with its tissue-expression profile in blue-eggshell Yimeng chickens (Gallus gallus).

Authors:  Jianfei Chen; Seyed Benyamin Dalirsefat; Deping Han; Xianggui Dong; Guoying Hua; Xiaotong Zheng; Tianlan Xia; Tianqi Shao; Xuemei Deng; Changxin Wu
Journal:  Poult Sci       Date:  2020-09-15       Impact factor: 3.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.